论文信息 - Complete molecular remission induced by rituximab in a patient with diffuse large cell lymphoma.

Complete molecular remission induced by rituximab in a patient with diffuse large cell lymphoma.

Haematologica vol. 85(4):April 2000 7. Hayata I, Sakurai M, Kakati S, Sandberg AA. Chromosome and causation of human cancer and leukemia. XVI. Banding studies of chronic myelocytic leukemia, including five unusual Ph11 translocations. Cancer 1975; 36:1177-91. 8. Becher R, Kuhn D, Prescher G, Schmidt CG. Atypical t(9;12;22), t(20;22) and t(12;22) in Philadelphia-positive CML. Cancer Genet Cytogenet 1987; 25:183-4. 9. Potter AM, Watmore AE, Cooke P, Lilleyman JS, Sokol RJ. Significance of non-standard Philadelphia chromosomes in chronic granulocytic leukemia. Br J Cancer 1981; 44:51-4. 10. O’Brien S, Thall PF, Siciliano MJ. Cytogenetics of chronic myelogenous leukaemia. Baillières Clin Haematol 1997; 10:259-76.

[1] R. Levy,et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2] M. Boccadoro,et al. High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting. , 1995, Blood.

[3] K. Maclennan,et al. The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4] D. Catovsky,et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. , 1991, Blood.

[5] S. Horning,et al. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. , 1984, The New England journal of medicine.

[6] V. Diehl,et al. Rituximab ( Anti-CD 20 Monoclonal Antibody ) for the Treatment of Patients With Relapsing or Refractory Aggressive Lymphoma : A Multicenter Phase II Study , 1998 .